Relationship of socio-demographics, comorbidities, symptoms and healthcare access with early COVID-19 presentation and disease severity

被引:24
作者
Vaughan, Laura [1 ,2 ]
Veruttipong, Darlene [1 ,3 ]
Shaw, Jonathan G. [1 ,3 ]
Levy, Noemie [4 ]
Edwards, Lauren [1 ,2 ]
Winget, Marcy [1 ,3 ]
机构
[1] Stanford Univ, Div Primary Care & Populat Hlth, Sch Med, 1265 Welch Rd,Mail Code 5475, Stanford, CA 94305 USA
[2] Stanford Primary Care Los Altos, 960 N San Antonio Rd 101, Los Altos, CA 94022 USA
[3] Stanford Univ, Dept Med, Evaluat Sci Unit, Sch Med, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, 291 Campus Dr, Stanford, CA 94305 USA
关键词
COVID-19; Race; Socio-demographics; Comorbidities; Symptoms;
D O I
10.1186/s12879-021-05764-x
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundCOVID-19 studies are primarily from the inpatient setting, skewing towards severe disease. Race and comorbidities predict hospitalization, however, ambulatory presentation of milder COVID-19 disease and characteristics associated with progression to severe disease is not well-understood.MethodsWe conducted a retrospective chart review including all COVID-19 positive cases from Stanford Health Care (SHC) in March 2020 to assess demographics, comorbidities and symptoms in relationship to: 1) their access point of testing (outpatient, inpatient, and emergency room (ER)) and 2) development of severe disease.ResultsTwo hundred fifty-seven patients tested positive: 127 (49%), 96 (37%), and 34 (13%) at outpatient, ER and inpatient, respectively. Overall, 61% were age<55; age>75 was rarer in outpatient setting (11%) than ER (14%) or inpatient (24%). Most patients presented with cough (86%), fever/chills (76%), or fatigue (63%). 65% of inpatients reported shortness of breath compared to 30-32% of outpatients and ER patients. Ethnic/minority patients had a significantly higher risk of developing severe disease (Asian OR=4.8 [1.6-14.2], Hispanic OR=3.6 [1.1-11.9]). Medicare-insured patients were marginally more likely (OR=4.0 [0.9-17.8]). Other factors associated with developing severe disease included kidney disease (OR=6.1 [1.0-38.1]), cardiovascular disease (OR=4.7 [1.0-22.1], shortness of breath (OR=5.4 [2.3-12.6]) and GI symptoms (OR=3.3 [1.4-7.7]; hypertension without concomitant CVD or kidney disease was marginally significant (OR=2.3 [0.8-6.5]).ConclusionsEarly widespread symptomatic testing for COVID-19 in Silicon Valley included many less severely ill patients. Thorough manual review of symptomatology reconfirms the heterogeneity of COVID-19 symptoms, and challenges in using clinical characteristics to predict decline. We re-demonstrate that socio-demographics are consistently associated with severity.
引用
收藏
页数:10
相关论文
共 13 条
[1]  
[Anonymous], HLTH US 2018 DATA FI
[2]  
[Anonymous], 2020, Evidence used to update the list of underlying medical conditions that create a person's risk of severe illness from COVID-19
[3]  
Artandi M., 2020, NEJM Catalyst, V2020, DOI DOI 10.1056/CAT.20.0100
[4]   Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California [J].
Azar, Kristen M. J. ;
Shen, Zijun ;
Romanelli, Robert J. ;
Lockhart, Stephen H. ;
Smits, Kelly ;
Robinson, Sarah ;
Brown, Stephanie ;
Pressman, Alice R. .
HEALTH AFFAIRS, 2020, 39 (07) :1253-1262
[5]  
Centers for Disease Control and Prevention, SELECTED HLTH CONDIT
[6]  
Centers for Disease Control and Prevention, UPDATED GUIDANCE EVA
[7]  
Hellmann J., 2020, FRUSTRATIONS GROW IN
[8]  
Hologic, SARS COV 2 ASSAY PAN
[9]  
Medium, ESTIMATING FEASIBILI
[10]   Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: A systematic review, meta-analysis and meta-regression [J].
Pranata, Raymond ;
Lim, Michael Anthonius ;
Huang, Ian ;
Raharjo, Sunu Budhi ;
Lukito, Antonia Anna .
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2020, 21 (02)